Genus plc (GENSY)
OTCMKTS · Delayed Price · Currency is USD
24.34
+1.34 (5.83%)
At close: Apr 11, 2025
Genus Revenue
In the fiscal year ending June 30, 2025, Genus had annual revenue of 672.80M GBP with 0.60% growth. Genus had revenue of 336.40M in the half year ending June 30, 2025, a decrease of -0.91%.
Revenue
672.80M GBP
Revenue Growth
+0.60%
P/S Ratio
2.44
Revenue / Employee
192.23K GBP
Employees
3,500
Market Cap
2.25B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2025 | 672.80M | 4.00M | 0.60% |
Jun 30, 2024 | 668.80M | -20.90M | -3.03% |
Jun 30, 2023 | 689.70M | 96.30M | 16.23% |
Jun 30, 2022 | 593.40M | 19.10M | 3.33% |
Jun 30, 2021 | 574.30M | 22.90M | 4.15% |
Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Veradigm | 588.02M |
Elite Pharmaceuticals | 105.45M |
Tian'an Technology Group | 2.12M |
Glass House Brands | 221.55M |
Northwest Biotherapeutics | 1.09M |
American Oncology Network | 1.76B |
Silence Therapeutics | 27.17M |
AMJ Global Technology | 39.00 |